Mariner
BCAB

Mariner’s BIOATLA INC BCAB Stock Holding History

Mariner’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-320
Closed -$2.58K – 3547
2026
Q1 		$2.58K Buy
+320
New +$3.75K ﹤0.01% 3537

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mariner's BCAB Position: Q2 2026 in Review

Mariner sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 320 shares — an estimated $2.58K sold.

Mariner first reported a position in BCAB in Q1 2026 and held it in 1 quarter. The position peaked at $2.58K in Q1 2026. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Mariner reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
  • Mariner sold 320 BIOATLA INC shares in Q2 2026, an estimated $2.58K.
  • Mariner first reported a position in BIOATLA INC in Q1 2026 and held it in 1 quarter.
  • Mariner's BIOATLA INC position peaked at $2.58K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.